Eritrea vs Nicaragua: Cause of death, by non-communicable diseases, female
Eritrea
56.4%
in 2021
Nicaragua
55.7%
in 2021
Eritrea rank
128th
Nicaragua rank
129th
Cause of death, by non-communicable diseases, female over time
- Eritrea
- Nicaragua
How they compare
Eritrea currently reports 56.4% against 55.7% in Nicaragua, a difference of 0.7%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Nicaragua ahead.
Eritrea ranks 128th and Nicaragua ranks 129th of 185 countries.
Nicaragua has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eritrea | Nicaragua | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 38.0% | 59.8% | 21.8% | Nicaragua |
| 2010s | 52.7% | 79.5% | 26.8% | Nicaragua |
| 2020s | 56.7% | 58.6% | 1.9% | Nicaragua |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Eritrea or Nicaragua?
- Eritrea, at 56.4% against 55.7% in Nicaragua as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Eritrea and Nicaragua?
- 0.7%, with Eritrea ahead.
- How many years of comparable data are there for Eritrea and Nicaragua?
- 6 years are reported by both, from 2000 to 2021.
- How do Eritrea and Nicaragua rank globally for cause of death, by non-communicable diseases, female?
- Eritrea ranks 128th and Nicaragua ranks 129th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.